Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead ...

Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a human vascularized liver cancer-on-a-chip model to evaluate vessel remodeling and cell death in response to embolic agents. This novel ...

Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead increase the risk of chronic liver damage and cancer as we age.

The global incidence of liver cancer is projected to double by 2050. Sixty percent of liver cancers are preventable by controlling risk factors including hepatitis B and C, alcohol consumption, and ...

Margot got the news in her early 20s: "You have liver cancer," her doctors told her. Specifically, Margot had a form of liver cancer known as fibrolamellar carcinoma, a diagnosis with deadly prospects ...